Diet supplements and gene therapy tried for Parkinson's disease
BMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7369.851 (Published 19 October 2002) Cite this as: BMJ 2002;325:851- Janice Hopkins Tanne
- New York
Two new experimental approaches—dietary supplements and gene therapy—might be useful in the treatment of Parkinson's disease, scientists from the United States and New Zealand said last week.
Functional decline in early Parkinson's disease may be slowed by dietary supplementation with the coenzyme Q10, a naturally occurring compound, says a report in the Archives of Neurology
(2002;59:1541-50), while the Food and Drug Administration has just approved the first gene therapy trial for advanced Parkinson's disease. The FDA's decision comes after the report of a successful experiment in gene therapy carried out in rats …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.